Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.
Submissions from 2025
9-1-2025 Evaluating Artificial Intelligence-Driven Responses to Acute Liver Failure Queries: A Comparative Analysis Across Accuracy, Clarity, and Relevance, Sheza Malik, Rochester Regional Health, Lewis J. Frey, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA., Jason Gutman, Rochester Regional Health, et al.
9-1-2025 HL-879: Immune Checkpoint Inhibition as a Bridge to Allogeneic Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: A Meta-Analysis, Pragya Jain, Viraj Panchal, Nency Ganatra, et al.
9-1-2025 Impact of glucagon-like peptide-1 receptor agonists on cutaneous events: A systematic review and meta-analysis, Chun-Chiao Yu, Nutchapon Xanthavanij, Tsu Hsien Wang, et al.
9-1-2025 In-hospital complications of hybrid vs endocardial atrial fibrillation ablation, Mahmoud Eisa, Rochester Regional Health, Nauman Naeem, Rochester Regional Health, Hossam Elbenawi, et al.
9-1-2025 Insulin Versus Established GLP-1 Receptor Agonists, DPP-4 Inhibitors, and SGLT-2 Inhibitors for Uncontrolled Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Ammar Ahmed, Zi Tan, Waddah Abd El-Radi, Rochester Regional Health, et al.
9-1-2025 MCL-803: Efficacy and Safety of Ibrutinib Combined With Venetoclax in the Treatment of Relapsed or Refractory Mantle Cell Lymphoma: A Systematic Review and Single-Arm Meta-Analysis, Omar Abdullah Gill, Zainab Sabir, Hafiz Muhammad Ehsan Arshad, et al.
9-1-2025 MDS-1451: Evolving Mortality Trends in Myelodysplastic Syndromes Among Older US Adults: A 25-Year Nationwide Joinpoint Analysis, Shaaf Ahmad, Maryam Maqsood, Rochester Regional Health, Mahnoor Shah, et al.
9-1-2025 MDS-963: Transfusion-Dependent MDS With Ring Sideroblasts and Incidental Low-Grade Lymphoma: A Complex Hematologic Intersection, Adithya Nagendran, Rochester Regional Health, Anushree Venkatesh Murthy, Rochester Regional Health, Mostafa Najim, Rochester Regional Health, et al.
9-1-2025 MM-1053: Cardiovascular Risk of CAR T-Cell and Bispecific Immunotherapies in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis, Lakshmi Sai Meghana Kodali, Maneeth Mylavarapu, Diksha Sanjana Pasnoor, et al.
9-1-2025 MM-901: Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Multiple Myeloma Patients (2016–2020), Purva Shah, Rochester Regional Health; Preetinder Singh Manshahia, Rochester Regional Health; and Ranjini Vengilote, Rochester Regional Health
9-1-2025 MM-903: Trends in Venous Thromboembolism Events in Hospitalized Multiple Myeloma Patients: A Retrospective Cohort Study, Preetinder Singh Manshahia, Rochester Regional Health; Purva Shah, Rochester Regional Health; and Ranjini Vengilote, Rochester Regional Health
9-1-2025 Plant Terpenoids in Combination with Conventional Therapeutics in Colorectal Cancer: A Promising Option, Chengu Niu, Rochester Regional Health; Jing Zhang, Rainier Springs Behavioral Health Hospital, Vancouver, WA, 98686, USA.; and Patrick I. Okolo, Division of Gastroenterology, Carillion Clinic, Roanoke, VA, 24014, USA.
9-1-2025 POSTER: ABCL-523 Breaking the Storm: Effective Rituximab Desensitization for Severe Cytokine Release Syndrome in Intravascular Large B-Cell Lymphoma, Adithya Nagendran, Rochester Regional Health; Anushree Venkatesh Murthy, Rochester Regional Health; and Joud Madani, Rochester Regional Health
9-1-2025 POSTER: AML-179 The Role of Interim Bone Marrow Assessments in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis, Yuanli Lei, Zhiting Tang, Rochester Regional Health, Jessica Reese, et al.
9-1-2025 POSTER: AML-751 Clinical Efficacy and Safety of Enasidenib in Newly Diagnosed IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Maneeth Mylavarapu, Lakshmi Sai Meghana Kodali, Nency Ganatra, et al.
9-1-2025 POSTER: AML-798 Efficacy and Safety of Gilteritinib Compared to Salvage Chemotherapy for R/R Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis, Muhammad Muneeb Khawar, Noormah Nasir, Omar Gill, et al.
9-1-2025 POSTER: CLL-787 Efficacy and Safety of Ibrutinib Combined With Venetoclax in the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis, Omar Gill, Maryam Maqsood, Rochester Regional Health, Muhammad Muneeb Khawar, et al.
9-1-2025 POSTER: CT-1007 Severe Cytokine Release Syndrome and Risk of Acute Kidney Injury in Patients With Hematologic Malignancies Undergoing CAR T-Cell Therapy: A Systematic Review and Meta-Analysis, Diksha Sanjana Pasnoor, Aditya Sanjeevi, Rochester Regional Health, Lakshmi Sai Meghana Kodali, et al.
9-1-2025 POSTER: CT-1429 Real-World Mortality Trends in Hematologic Malignancies Following the Introduction of CAR-T Therapy: A 20-Year US Population-Based Study, Shaaf Ahmad, Maryam Maqsood, Rochester Regional Health, Mahnoor Shah, et al.
9-1-2025 POSTER: CT-894 Incidence of Cytokine Release Syndrome-Associated Coagulopathy and Disseminated Intravascular Coagulation Following CAR-T Therapy: A Systematic Review and Meta-Analysis, Aditya Sanjeevi, Rochester Regional Health, Diksha Sanjana Pasnoor, Lakshmi Sai Meghana Kodali, et al.
9-1-2025 POSTER: HL-879 Immune Checkpoint Inhibition as a Bridge to Allogeneic Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: A Meta-Analysis, Pragya Jain, Viraj Panchal, Nency Ganatra, et al.
9-1-2025 POSTER: MCL-803 Efficacy and Safety of Ibrutinib Combined With Venetoclax in the Treatment of Relapsed or Refractory Mantle Cell Lymphoma: A Systematic Review and Single-Arm Meta-Analysis, Omar Abdullah Gill, Zainab Sabir, Hafiz Muhammad Ehsan Arshad, et al.
9-1-2025 POSTER: MDS-1451 Evolving Mortality Trends in Myelodysplastic Syndromes Among Older US Adults: A 25-Year Nationwide Joinpoint Analysis, Shaaf Ahmad, Maryam Maqsood, Rochester Regional Health, Mahnoor Shah, et al.
9-1-2025 POSTER: MM-1053 Cardiovascular Risk of CAR T-Cell and Bispecific Immunotherapies in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis, Lakshmi Sai Meghana Kodali, Maneeth Mylavarapu, Diksha Sanjana Pasnoor, et al.
9-1-2025 POSTER: MM-901 Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Multiple Myeloma Patients (2016–2020), Purva Shah, Rochester Regional Health; Preetinder Singh Manshahia, Rochester Regional Health; and Ranjini Vengilote, Rochester Regional Health